Cetuximab (Erbitux) for the treatment of patients with metastasising intestinal cancer - accelerated assessment
Danish Centre for Evaluation and Health Technology Assessment
Record ID 32006000487
Danish
Details
Project Status:
Completed
Year Published:
2006
URL for published report:
n/a
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Denmark
MeSH Terms
- Drug Evaluation
- Neoplasm Metastasis
- Outcome Assessment, Health Care
- Antibodies, Monoclonal
- Antineoplastic Agents
- Intestinal Neoplasms
Contact
Organisation Name:
Danish Centre for Evaluation and Health Technology Assessment
Contact Address:
National Board of Health, PO Box 1881, Islands Brygge 67, DK-2300 Copenhagen S, Denmark. Tel: 45 72 22 74 48; Fax: 45 72 22 74 07/67
Contact Name:
dacehta@sst.dk
Contact Email:
dacehta@sst.dk
Copyright:
Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.